Skip to main content
. 2019 Mar 3;10(7):1642–1650. doi: 10.7150/jca.28266

Figure 1.

Figure 1

Mutations identified in primary tumors and metastatic lesions. The number of non-synonymous variants identified in primary tumors, metastatic lesions, and both tumor and metastatic lesions in LUAD (A) and LUSC (B). The number of amplifications and homozygous deletions in primary tumors, metastatic lesions, and both tumor and metastatic lesions in LUAD (C) and LUSC (D).